Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
Ahmed O. Kaseb, Elshad Hasanov(The University of Texas MD Anderson Cancer Center), Hop Sanderson Tran Cao(The University of Texas MD Anderson Cancer Center), Lianchun Xiao(The University of Texas MD Anderson Cancer Center), Jean‐Nicolas Vauthey(The University of Texas MD Anderson Cancer Center), Sunyoung S. Lee(The University of Texas MD Anderson Cancer Center), Betül Gök Yavuz(The University of Texas MD Anderson Cancer Center), Yehia I. Mohamed(The University of Texas MD Anderson Cancer Center), Aliya Qayyum(The University of Texas MD Anderson Cancer Center), Sonali Jindal(The University of Texas MD Anderson Cancer Center), Fei Duan(The University of Texas MD Anderson Cancer Center), Sreyashi Basu(The University of Texas MD Anderson Cancer Center), Shalini S. Yadav(The University of Texas MD Anderson Cancer Center), Courtney Nicholas(The University of Texas MD Anderson Cancer Center), Jing Sun(The University of Texas MD Anderson Cancer Center), Kanwal Raghav(The University of Texas MD Anderson Cancer Center), Asif Rashid(The University of Texas MD Anderson Cancer Center), Kristen Carter(The University of Texas MD Anderson Cancer Center), Yun Shin Chun(The University of Texas MD Anderson Cancer Center), Ching‐Wei D. Tzeng(The University of Texas MD Anderson Cancer Center), Divya Sakamuri(The University of Texas MD Anderson Cancer Center), Li Xu(The University of Texas MD Anderson Cancer Center), Ryan Sun(The University of Texas MD Anderson Cancer Center), Vittorio Cristini(Houston Methodist), Laura Beretta, James C. Yao(The University of Texas MD Anderson Cancer Center), Robert A. Wolff(The University of Texas MD Anderson Cancer Center), James P. Allison, Padmanee Sharma
Cited by 252Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis